anonymous
Guest
anonymous
Guest
Absent ALKS 5461, Alkermes future revenue growth will rely more heavily on the recently approved, long-acting schizophrenia drug Aristada,
Otsuka here. Well the quote above should make all of you feel better about joining Alkermes. As bad as you have it now, it's still 10x better than at this shithole of a company. I will say that Aristada is all but dead in my area, but then so are all my Otsuka buddies!
Good luck to you guys! You took a chance, and it may still pay off.